tailieunhanh - Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab

KRAS mutations have been characterized as the major predictive biomarkers for resistance to cetuximab treatment. However, studies indicate that not all KRAS mutations are associated with equivalent treatment outcomes. | Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN